Clinical Features in Very Early-Onset Demyelinating Disease With Anti-Mog Antibody

Brain and Development - Netherlands
doi 10.1016/j.braindev.2017.05.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Anti-Mog Autoantibodies Pathogenicity in Children and Macaques Demyelinating Diseases

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2019English

Apolipoprotein E Genotype and Concomitant Clinical Features in Early-Onset Alzheimer's Disease

Journal of Neurology
Neurology
1996English

Recent Advance in Very Early Onset Inflammatory Bowel Disease

Intestinal Research
Gastroenterology
2019English

Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire With Fire?

Digestion
Gastroenterology
2017English

Clinical Features of Several Connective Tissue Diseases With Anti-Golgi Antibody

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2001English

MOG Antibody-Associated Diseases

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2015English

Clinical Features and Laboratory Findings in Children With Both Anti-dsDNA and Anti-U1-RNP Antibody

Japanese Journal of Clinical Immunology
2008English

Clinical Commentary on ‘Late-Onset Neutropenia and Neurological Relapse During Long-Term Rituximab Therapy in MOG Antibody Spectrum Disorder’

Multiple Sclerosis
Neurology
2018English

Clinical Features of Catheter-Related Candidemia at Disease Onset

Singapore Medical Journal
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy